Remote delivery of psychological interventions for Parkinson's disease.
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 28 of the 120 sources its claims cite were checked for support.
Abstract
ABSTRACTObjective:Over two-thirds of Parkinson's disease (PD) patients experience comorbid neuropsychiatric symptoms, which adversely impact their quality of life and often require intervention. There is a preference for non-pharmacological, psychological approaches in addressing these symptoms. Given mobility limitations, travel burden, and cost, accessibility to psychological treatment can be problematic in this population. There has been a recent shift toward delivering care via telehealth in PD. Accordingly, this review aimed to examine remotely delivered psychological interventions for PD patients.Results:Most of the telehealth studies for PD involved Cognitive Behavioral Therapy (CBT) based anxiety and depression telephone interventions with relatively short (one month) follow-up periods.Conclusion:Although a preliminary work indicates efficacy, future studies should demonstrate the non-inferiority of these telehealth programs compared to face-to-face delivery, and examine the long-term outcomes of remotely delivered therapy. Video-conferencing (VC) appears to be a promising modality to overcome noted limitations of telephone delivery, and has demonstrated efficacy for PD speech programs. Further research should be conducted evaluating telehealth VC modalities for delivery of psychotherapy including CBT, as well as mindfulness-based therapy and acceptance and commitment therapy for remote treatment of depression and anxiety in PD.
Overview
CoChat Summary
TL;DR
This narrative review examines remotely delivered psychological interventions for Parkinson's disease (PD), finding that most telehealth work consists of telephone-administered CBT for anxiety and/or depression, with preliminary but variable efficacy. The authors conclude that video-conferencing is a promising but untested modality for psychotherapy in PD and call for large non-inferiority trials with longer follow-up.
Key findings
- Only five telehealth-based psychological intervention studies for PD anxiety/depression had been published: three telephone-delivered CBT trials (Veazey et al., 2009; Dobkin et al., 2011b; Calleo et al., 2015), one hybrid bibliotherapy-plus-telephone-support study (Lawson et al., 2013), and one internet-administered CBT study with telephone support (Kraepelien et al., 2015). All were pilot studies targeting comorbid depression and/or anxiety in older PD patients via one-on-one CBT.
- Outcomes were promising but variable: significant improvements were reported for anxiety only (Veazey et al., 2009), depression only (Calleo et al., 2015), or both (Dobkin et al., 2011b). In Calleo et al. (2015), between-group effect sizes were large despite only post-intervention depression reduction reaching significance (post-treatment d = 1.49 depression, 1.44 anxiety; one-month follow-up d = 0.73 depression, 1.24 anxiety). Dobkin et al. (2011b) reported post-treatment d = 1.21 for depression and 1.09 for anxiety.
- In Lawson et al. (2013), the intervention group showed significant within-group worry reduction from baseline (M = 48.82, SD = 15.97) to three-month follow-up (M = 41.88, SD = 18.00, Z = −2.35, p = 0.019), but no significant between-group difference; only 20% of the intervention group attempted all self-directed exercises, and attrition reduced the sample from 54 to 32. Kraepelien et al. (2015) found significant reduction in depression only (mean difference = −2.8, 95% CI = −5.4 to −0.1; d = 1.08; t(8) = 2.44; p < 0.05), with therapists spending less than 13 minutes per participant per week and one-third of patients ceasing treatment prematurely.
- The Parkinson's Active Living (PAL) program (Butterfield et al., 2016), a six-week telehealth behavioral activation intervention targeting apathy, showed significant improvements in apathy (d = 0.77) and depression (d = 0.70) maintained one month post-program, with apathy decreasing to normal limits for over a third of the sample; attrition was low despite no caregiver involvement.
- Retention appeared higher where caregivers were included (Dobkin et al., 2011b: 95%; Calleo et al., 2015: 69%), and intact verbal memory was associated with better response to telephone-based CBT, while verbal phonemic fluency correlated with apathy-specific treatment response in PAL — suggesting these interventions suit patients without extensive cognitive impairment.
Methods
- Narrative review. Major electronic databases (PubMed, PsycInfo, Web of Science) were searched using terms including Parkinson's disease, telehealth, telephone, video-conferencing, ehealth, psychotherapy, cognitive behavioral therapy, acceptance and commitment therapy, and mindfulness.
- Inclusion criteria: published in English in a peer-reviewed journal; evaluated a detailed psychological treatment as the primary intervention for PD patients; and the majority of treatment delivered remotely (initial and/or final session could be in-person). All trials, including uncontrolled pilot studies, published up to December 2016 were eligible; abstracts were screened and reference lists of identified articles checked for additional citations.
- Studies were excluded if psychiatric symptoms were secondary outcomes of non-psychotherapy interventions or of remote assessment/monitoring without treatment, or if they evaluated remote care across multiple subspecialties/conditions.
Limitations
- Stated by the authors: all identified studies were preliminary pilots with small samples and limited statistical power; several lacked control groups (e.g., Dobkin et al., 2011b; Kraepelien et al., 2015); follow-up was limited to one month in the telephone CBT studies, leaving long-term effects unknown; Calleo et al. (2015) allowed patients to self-select face-to-face or telephone delivery, limiting independent evaluation of telephone efficacy; no study assessed apathy or motivation in the self-directed programs; none reported whether landline or mobile devices were used; and most studies used anxiety/depression measures not validated or appropriately adjusted for PD (only Calleo et al. used a recommended scale, the GDS-15, but without the adjusted cut-off).
- Evident from the text: the evidence base is very small (five anxiety/depression studies plus one apathy study), no study has delivered mindfulness-based therapy, ACT, or interventions for impulse-control disorders remotely, and no study has used video-conferencing for psychological intervention delivery in PD, so the authors' recommendation of VC rests on evidence from speech telerehabilitation rather than psychotherapy trials.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
27 Valid · 8 Not valid · 65 Not checked · 52 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“PD patients report specific interest in care delivered via home-based telehealth interventions (Dobkin et al., 2013”
What the sources say
- Supportedcites Dobkin et al., 2013 matched to “Barriers to mental health care utilization in Parkinson's disease” (2013) source
In Results > Mental Health Needs Assessment and Tele-health Interventions, 84.8% of respondents said they would be more motivated to receive recommended specialty care if they could receive it at home. The same section reports that 68% were interested in telephone-based mental health interventions, supporting the paraphrase about interest in home-based telehealth care. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites Lubomski et al., 2013 matched to “A cross-sectional study of clinical management, and provision of health services and their utilisation, by patients with Parkinson's disease in urban and regional Victoria” (2013) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“impulse-control disorder (ICD) development in PD patients has been associated with dopamine agonist pharmacotherapy (Weintraub et al., 2006”
What the sources say
- Supportedcites Weintraub et al., 2006 matched to “Association of dopamine agonist use with impulse control disorders in Parkinson disease” (2006) source
The Results report that dopamine agonist treatment predicted a current impulse-control disorder in patients with Parkinson disease (P = .01). The Conclusions also advise monitoring treated patients for the risk of developing an ICD, supporting the claim’s association wording. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“are thought to be the strongest PD quality of life predictors (Rahman et al., 2008”
What the sources say
- Not checked — no full text of the sourcecites Rahman et al., 2008 matched to “Quality of life in Parkinson's disease: the relative importance of the symptoms” (2008) source
- Partly supportedcites Quelhas and Costa, 2009 matched to “Anxiety, depression, and quality of life in Parkinson's disease” (2009) sourceExperimental — accuracy not yet measured
The Multiple Regression Analysis identifies the combined anxiety-and-depression scale score as the strongest predictor of global quality of life. But when the symptoms were analyzed separately, anxiety had the largest coefficient and depression's was nonsignificant. The paper therefore does not support calling both symptoms individually the strongest predictors. (LLM, conf=0.88)
- Partly supportedcites Menon et al., 2015 matched to “Parkinson's disease, depression, and quality-of-life” (2015) sourceExperimental — accuracy not yet measured
The Discussion identifies depression as the most important predictor of poor quality of life in this study. It also states that psychiatric conditions other than depression were not considered, so the paper does not establish anxiety as one of the strongest predictors. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Many PD patients, however, do not receive mental health treatment (Frisina et al., 2008”
What the sources say
- Not matchedcites Frisina et al., 2008
An author–year citation the paper’s reference list doesn’t settle. We don’t search these by name.
- Supportedcites Dobkin et al., 2013 matched to “Barriers to mental health care utilization in Parkinson's disease” (2013) source
The Discussion reports that approximately 30% of respondents who said they needed help for depression or anxiety remained untreated. The Results likewise report that 73.4% of those expressing a need received treatment, supporting the claim that many did not. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“and has been well-received by patients”
What the sources say
- Not checked — no full text of the sourcecites Constantinescu et al., 2010 matched to “Home-based speech treatment for Parkinson's disease delivered remotely: a case report” (2010) source
- Not checked — no full text of the sourcecites Constantinescu et al., 2011 matched to “Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial” (2011) source
- Supportedcites Dias et al., 2016 matched to “Telerreabilitação vocal na doença de Parkinson” (2016) source
The Abstract reports that 20 patients with Parkinson’s disease received the extended Lee Silverman treatment using videoconferencing. It states that all patients reported satisfaction with telerehabilitation and preferred it to face-to-face rehabilitation, supporting the claim that patients received it well. (LLM, conf=0.94)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
75 more claims · 9 with their cited sources checked
Create a free account to see all 152 claims and every source verdict.
- Probably not a substantial claim. 44
- It may state two separate claims as one. 34
- The quote only partly states this claim. 2
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentz = -2.35reported p = .019 · recomputed p = .019
“Z = −2.35, p = .019”
- Consistentt(8) = 2.44reported p < .05 · recomputed p = .041
“t(8) = 2.44, p < .05”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Citations
Cites
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
What contributes to quality of life in patients with Parkinson's disease?
Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.3.308 · Cited by 1,380 · cited 2×
“…(Riedel et al., 2010), are increasingly recognized as important contributors to patient disability (Weintraub et al., 2004), quality of life (Schrag et al., 2000; Schrag, 2006; Dissanayaka et al., 2010; Martinez-Martin et al., 2011; Jiang et al., 2013), and mortality (Hughes et al., 2004).”
BackgroundA systematic review of prevalence studies of depression in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Weber, W. E. J., Aarsland, D., & Leentjens, A. F. G. (2008) · Movement Disorders · doi:10.1002/mds.21803 · Cited by 1,239 · cited 2×
“in 35% of patients (Reijnders et al., 2008), are thought to be the strongest PD quality of life predictors (Rahman et al.”
BackgroundMartinez‐Martin, P., Rodriguez‐Blazquez, C., Kurtis, M. M., Chaudhuri, K. R., & on Behalf of the NMSS Validation Group (2011) · Movement Disorders · doi:10.1002/mds.23462 · Cited by 989 · cited 2×
“…(Riedel et al., 2010), are increasingly recognized as important contributors to patient disability (Weintraub et al., 2004), quality of life (Schrag et al., 2000; Schrag, 2006; Dissanayaka et al., 2010; Martinez-Martin et al., 2011; Jiang et al., 2013), and mortality (Hughes et al., 2004).”
BackgroundAssociation of dopamine agonist use with impulse control disorders in Parkinson disease
Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.969 · Cited by 662
Range of neuropsychiatric disturbances in patients with Parkinson's disease
Aarsland, D., Larsen, J. P., Lim, N. G., Janvin, C., Karlsen, K., Tandberg, E., & Cummings, J. L. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.492 · Cited by 581
Quality of life in Parkinson's disease: the relative importance of the symptoms
Rahman, S., Griffin, H. J., Quinn, N. P., & Jahanshahi, M. (2008) · Movement Disorders · doi:10.1002/mds.21667 · Cited by 532 · cited 2×
“First published online 11 May 2018. in 35% of patients (Reijnders et al., 2008), are thought to be the strongest PD quality of life predictors (Rahman et al., 2008; Quelhas and Costa, 2009; Menon et al., 2015).”
BackgroundPrevalence of anxiety in Parkinson's disease: A systematic review and meta‐analysis
Broen, M. P. G., Narayen, N. E., Kuijf, M. L., Dissanayaka, N. N. W., & Leentjens, A. F. G. (2016) · Movement Disorders · doi:10.1002/mds.26643 · Cited by 457 · cited 2×
“In fact, anxiety, which is experienced in an average of 31% of PD patients (Broen et al., 2016), and depression, observed”
BackgroundSelf-citationAnxiety disorders in Parkinson's disease: Prevalence and risk factors
Dissanayaka, N. N. W., Sellbach, A., Matheson, S., O'Sullivan, J. D., Silburn, P. A., Byrne, G. J., Marsh, R., & Mellick, G. D. (2010) · Movement Disorders · doi:10.1002/mds.22833 · Cited by 408
Self-citationEffect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease
Weintraub, D., Moberg, P. J., Duda, J. E., Katz, I. R., & Stern, M. B. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52219.x · Cited by 381 · cited 5×
“As indicated above, apathy is being recognized as an increasingly important PD comorbidity, not necessarily associated with depression, which has been found to interfere with PD motor disability treatment, exacerbating disability, and lowering quality of life and ability to carry out activities of daily living (ADL) (…”
BackgroundInfluentialQuality of life and depression in Parkinson's disease
Schrag, A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.030 · Cited by 379 · cited 2×
“…(Riedel et al., 2010), are increasingly recognized as important contributors to patient disability (Weintraub et al., 2004), quality of life (Schrag et al., 2000; Schrag, 2006; Dissanayaka et al., 2010; Martinez-Martin et al., 2011; Jiang et al., 2013), and mortality (Hughes et al., 2004).”
BackgroundApathy in Parkinson's disease: A systematic review and meta‐analysis
den Brok, M. G. H. E., van Dalen, J. W., van Gool, W. A., Moll van Charante, E. P., de Bie, R. M. A., & Richard, E. (2015) · Movement Disorders · doi:10.1002/mds.26208 · Cited by 376 · cited 1×
“Apathy is a common neuropsychiatric symptom in PD, affecting up to 40% of patients (den Brok et al., 2015), which could limit the capacity for selfdirected care.”
BackgroundCognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111669 · Cited by 310
Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5465-z · Cited by 256
Randomized controlled clinical trial of “virtual house calls” for Parkinson disease
Dorsey, E. R., Venkataraman, V., Grana, M. J., Bull, M. T., George, B. P., Boyd, C. M., Beck, C. A., Rajan, B., Seidmann, A., & Biglan, K. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.123 · Cited by 235
Mortality in Parkinson's disease and its association with dementia and depression
Hughes, T. A., Ross, H. F., Mindham, R. H. S., & Spokes, E. G. S. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00292.x · Cited by 220 · cited 1×
“…(Riedel et al., 2010), are increasingly recognized as important contributors to patient disability (Weintraub et al., 2004), quality of life (Schrag et al., 2000; Schrag, 2006; Dissanayaka et al., 2010; Martinez-Martin et al., 2011; Jiang et al., 2013), and mortality (Hughes et al., 2004).”
BackgroundTrial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S. S., Chaudhuri, K. R., Martin, A., Mack, J., Brown, R. G., & David, A. S. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840678 · Cited by 202
Constantinescu, G., Theodoros, D., Russell, T., Ward, E., Wilson, S., & Wootton, R. (2011) · International Journal of Language & Communication Disorders · doi:10.3109/13682822.2010.484848 · Cited by 192 · cited 3×
“The success of vocal telerehabilitation programs delivered via VC for PD could provide a guiding framework for clinicians intending to adapt telephone-delivered psychological interventions (Constantinescu et al., 2010; 2011; Dias et al., 2016; Theodoros et al., 2016).”
BackgroundMethodPrevalence and treatment of depression in Parkinson's disease
Veazey, C., Ozlem Erden Aki, S., Cook, K. F., Lai, E. C., & Kunik, M. E. (2005) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.17.3.310 · Cited by 162 · cited 2×
“, 2013), and concerns regarding unfavorable side effects, including exacerbation of motor problems in patients with complex medication regimes, have been noted (Rabinstein and Shulman, 2000; Veazey et al., 2005; Chen and Marsh, 2014).”
BackgroundAnxiety in Parkinson's disease: identification and management
Chen, J. J., & Marsh, L. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613495723 · Cited by 161 · cited 2×
“, 2013), and concerns regarding unfavorable side effects, including exacerbation of motor problems in patients with complex medication regimes, have been noted (Rabinstein and Shulman, 2000; Veazey et al., 2005; Chen and Marsh, 2014).”
BackgroundA qualitative analysis of mindfulness‐based cognitive therapy (MBCT) in Parkinson's disease
Fitzpatrick, L., Simpson, J., & Smith, A. (2010) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1348/147608309x471514 · Cited by 136 · cited 1×
“…Dissanayaka et al., 2016a) and non-motor symptoms, including depression (Cash et al., 2016; Dissanayaka et al., 2016a), anxiety (Dissanayaka et al., 2016a), cognition (Cash et al., 2016; Dissanayaka et al., 2016a), distress (Dissanayaka et al., 2016a), and coping skills (Fitzpatrick et al., 2010).”
BackgroundTroeung, L., Egan, S. J., & Gasson, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079510 · Cited by 132 · cited 2×
“Evidence for the effectiveness of pharmacological interventions in treating PD neuropsychiatric symptoms is mixed (Price et al., 2011; Troeung et al., 2013), and concerns regarding unfavorable side effects, including exacerbation of motor problems in patients with complex medication regimes, have…”
BackgroundBenito‐León, J., Cubo, E., Coronell, C., & on behalf of the ANIMO Study Group (2012) · Movement Disorders · doi:10.1002/mds.23872 · Cited by 129 · cited 3×
“…not necessarily associated with depression, which has been found to interfere with PD motor disability treatment, exacerbating disability, and lowering quality of life and ability to carry out activities of daily living (ADL) (Weintraub et al., 2004; Benito-Leon et al., 2012; Laatu et al., 2013).”
BackgroundTheodoros, D. G., Hill, A. J., & Russell, T. G. (2016) · American Journal of Speech-Language Pathology · doi:10.1044/2015_ajslp-15-0005 · Cited by 110 · cited 3×
“The success of vocal telerehabilitation programs delivered via VC for PD could provide a guiding framework for clinicians intending to adapt telephone-delivered psychological interventions (Constantinescu et al., 2010; 2011; Dias et al., 2016; Theodoros et al., 2016).”
BackgroundMethodCognitive-behavioral therapy for depression in Parkinson's disease: a pilot study
Dobkin, R. D., Allen, L. A., & Menza, M. (2007) · Movement Disorders · doi:10.1002/mds.21455 · Cited by 107 · cited 2×
“The success of face-to-face cognitive behavioral therapy (CBT) in addressing comorbid depression and/or anxiety (Feeney et al., 2005; Dobkin et al., 2007; Dobkin et al., 2011a; Okai et al., 2013; Troeung et al., 2014; Shinmei et al., 2016) and ICDs (Okai et al.”
BackgroundAnxiety, depression, and quality of life in Parkinson's disease
Quelhas, R., & Costa, M. (2009) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.2009.21.4.413 · Cited by 100 · cited 1×
“, 2008), are thought to be the strongest PD quality of life predictors (Rahman et al., 2008; Quelhas and Costa, 2009; Menon et al., 2015).”
BackgroundAdvocat, J., Enticott, J., Vandenberg, B., Hassed, C., Hester, J., & Russell, G. (2016) · BMC Neurology · doi:10.1186/s12883-016-0685-1 · Cited by 94 · cited 1×
“A recent six-week group mindfulness intervention involving lifestyle management strategies for PD patients showed a significant reduction in depression and stress, and improvements in mindfulness and ADL at sixmonth follow-up (Advocat et al., 2016).”
BackgroundBarriers to mental health care utilization in Parkinson's disease
Dobkin, R. D., Rubino, J. T., Friedman, J., Allen, L. A., Gara, M. A., & Menza, M. (2013) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713481269 · Cited by 93 · cited 4×
“PD patients report specific interest in care delivered via homebased telehealth interventions (Dobkin et al., 2013; Lubomski et al., 2013).”
BackgroundInfluentialPrice, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230862 · Cited by 90
Telephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease
Dobkin, R. D., Menza, M., Allen, L. A., Tiu, J., Friedman, J., Bienfait, K. L., Gara, M. A., & Mark, M. H. (2011) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988711422529 · Cited by 88
Cash, T. V., Ekouevi, V. S., Kilbourn, C., & Lageman, S. K. (2016) · Mindfulness · doi:10.1007/s12671-015-0452-1 · Cited by 86 · cited 2×
“…demonstrated shortterm improvements in motor symptoms (Pickut et al., 2015; Dissanayaka et al., 2016a) and non-motor symptoms, including depression (Cash et al., 2016; Dissanayaka et al., 2016a), anxiety (Dissanayaka et al., 2016a), cognition (Cash et al., 2016; Dissanayaka et al., 2016a),…”
BackgroundTroeung, L., Egan, S. J., & Gasson, N. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-19 · Cited by 85 · cited 2×
“The success of face-to-face cognitive behavioral therapy (CBT) in addressing comorbid depression and/or anxiety (Feeney et al., 2005; Dobkin et al., 2007; Dobkin et al., 2011a; Okai et al., 2013; Troeung et al., 2014; Shinmei et al., 2016) and ICDs (Okai et al.”
BackgroundClinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease
Pachana, N. A., Egan, S. J., Laidlaw, K., Dissanayaka, N., Byrne, G. J., Brockman, S., Marsh, R., & Starkstein, S. (2013) · Movement Disorders · doi:10.1002/mds.25689 · Cited by 82
Self-citationDepression in Parkinson’s disease: Health risks, etiology, and treatment options
Borod, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1453 · Cited by 82 · cited 2×
“Many PD patients, however, do not receive mental health treatment (Frisina et al., 2008; Dobkin et al., 2013), given their significant mobility impairments, a lack of available services locally (and a high prevalence of rural and remote PD patients), and 1784 C. Swalwell et al. transportation…”
BackgroundMindfulness Training among Individuals with Parkinson’s Disease: Neurobehavioral Effects
Pickut, B., Vanneste, S., Hirsch, M. A., Van Hecke, W., Kerckhofs, E., Mariën, P., Parizel, P. M., Crosiers, D., & Cras, P. (2015) · Parkinson's Disease · doi:10.1155/2015/816404 · Cited by 80
Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson’s Disease
Dissanayaka, N. N. W., Idu Jion, F., Pachana, N. A., O’Sullivan, J. D., Marsh, R., Byrne, G. J., & Harnett, P. (2016) · Parkinson's Disease · doi:10.1155/2016/7109052 · Cited by 79
Self-citationVeazey, C., Cook, K. F., Stanley, M., Lai, E. C., & Kunik, M. E. (2009) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-009-9167-6 · Cited by 75 · cited 8×
“Results are promising but variable, with significant improvements reported for anxiety only (Veazey et al., 2009), depression only (Calleo et al., 2015), or both depression and anxiety (Dobkin et al., 2011b).”
BackgroundInfluentialAnxiety rating scales in Parkinson's disease: a critical review updating recent literature
Dissanayaka, N. N. W., Torbey, E., & Pachana, N. A. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215000885 · Cited by 74 · cited 2×
“Future anxiety interventions could utilize the Parkinson’s Anxiety Scale and/or the Geriatric Anxiety Inventory for assessment, both of which have now been validated for use in PD patients (Dissanayaka et al., 2015).”
BackgroundMethodSelf-citationHome-based speech treatment for Parkinson's disease delivered remotely: a case report
Constantinescu, G. A., Theodoros, D. G., Russell, T. G., Ward, E. C., Wilson, S. J., & Wootton, R. (2010) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2009.090306 · Cited by 72 · cited 2×
“The success of vocal telerehabilitation programs delivered via VC for PD could provide a guiding framework for clinicians intending to adapt telephone-delivered psychological interventions (Constantinescu et al., 2010; 2011; Dias et al., 2016; Theodoros et al., 2016).”
BackgroundMethodCalleo, J. S., Amspoker, A. B., Sarwar, A. I., Kunik, M. E., Jankovic, J., Marsh, L., York, M., & Stanley, M. A. (2015) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988715588831 · Cited by 71
Disease-specific anxiety symptomatology in Parkinson's disease
Dissanayaka, N. N. W., O'Sullivan, J. D., Pachana, N. A., Marsh, R., Silburn, P. A., White, E. X., Torbey, E., Mellick, G. D., Copland, D. A., & Byrne, G. J. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215002410 · Cited by 59
Self-citationParkinson's disease, depression, and quality-of-life
Menon, B., Nayar, R., Kumar, S., Cherkil, S., Venkatachalam, A., Surendran, K., & Deepak, K. S. (2015) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.155611 · Cited by 57
Telerreabilitação vocal na doença de Parkinson
Dias, A. E., Limongi, J. C. P., Barbosa, E. R., & Hsing, W. T. (2016) · CoDAS · doi:10.1590/2317-1782/20162015161 · Cited by 49 · cited 3×
“The success of vocal telerehabilitation programs delivered via VC for PD could provide a guiding framework for clinicians intending to adapt telephone-delivered psychological interventions (Constantinescu et al., 2010; 2011; Dias et al., 2016; Theodoros et al., 2016).”
BackgroundMethodFeeney, F., Egan, S., & Gasson, N. (2005) · Clinical Psychologist · doi:10.1080/13284200500048240 · Cited by 43 · cited 2×
“The success of face-to-face cognitive behavioral therapy (CBT) in addressing comorbid depression and/or anxiety (Feeney et al., 2005; Dobkin et al., 2007; Dobkin et al., 2011a; Okai et al., 2013; Troeung et al., 2014; Shinmei et al., 2016) and ICDs (Okai et al.”
BackgroundLubomski, M., Louise Rushworth, R., Lee, W., Bertram, K., & Williams, D. R. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.05.015 · Cited by 41 · cited 1×
“PD patients report specific interest in care delivered via homebased telehealth interventions (Dobkin et al., 2013; Lubomski et al., 2013).”
BackgroundButterfield, L. C., Cimino, C. R., Salazar, R., Sanchez-Ramos, J., Bowers, D., & Okun, M. S. (2017) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716673467 · Cited by 38 · cited 4×
“The PAL program (Butterfield et al., 2016) appears to be the first intervention developed to address this need.”
BackgroundInfluentialApathy is associated with activities of daily living ability in Parkinson's disease
Laatu, S., Karrasch, M., Martikainen, K., & Marttila, R. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000347129 · Cited by 37 · cited 3×
“…not necessarily associated with depression, which has been found to interfere with PD motor disability treatment, exacerbating disability, and lowering quality of life and ability to carry out activities of daily living (ADL) (Weintraub et al., 2004; Benito-Leon et al., 2012; Laatu et al., 2013).”
BackgroundBarbour, P. J., Arroyo, J., High, S., Fichera, L. B., Staska-Pier, M. M., & McMahon, M. K. (2016) · Hospital Practice · doi:10.1080/21548331.2016.1166922 · Cited by 34 · cited 1×
“Furthermore, remotely delivered assessments for PD patients in care facilities have demonstrated high patient and family satisfaction in addition to cost-effectiveness compared to transporting patients for face-to-face neurologist appointments (Barbour et al., 2016).”
BackgroundManagement of behavioral and psychiatric problems in Parkinson's disease
Rabinstein, A. A., & Shulman, L. M. (2000) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00039-0 · Cited by 30 · cited 2×
“, 2013), and concerns regarding unfavorable side effects, including exacerbation of motor problems in patients with complex medication regimes, have been noted (Rabinstein and Shulman, 2000; Veazey et al., 2005; Chen and Marsh, 2014).”
BackgroundGuided self-help for the management of worry in parkinson's disease: A pilot study
Lawson, R. A., Millar, D., Brown, R. G., & Burn, D. J. (2013) · Journal of Parkinson's Disease · doi:10.3233/jpd-120156 · Cited by 29 · cited 12×
“…CBT (Veazey et al., 2009; Dobkin et al., 2011b; Calleo et al., 2015), one involved a hybrid of CBT-based bibliotherapy and telephone support (Lawson et al., 2013), and one involved internet-administered CBT (in the form of self-paced, online modules) with supplementary telephone support…”
BackgroundMethodInfluentialKraepelien, M., Svenningsson, P., Lindefors, N., & Kaldo, V. (2015) · Internet Interventions · doi:10.1016/j.invent.2014.11.006 · Cited by 27 · cited 7×
“, 2013), and one involved internet-administered CBT (in the form of self-paced, online modules) with supplementary telephone support (Kraepelien et al., 2015).”
BackgroundMethodInfluentialAchey, M. A., Beck, C. A., Beran, D. B., Boyd, C. M., Schmidt, P. N., Willis, A. W., Riggare, S. S., Simone, R. B., Biglan, K. M., & Dorsey, E. R. (2014) · Trials · doi:10.1186/1745-6215-15-465 · Cited by 27
Neuropsychological Outcomes After Psychosocial Intervention for Depression in Parkinson’s Disease
Dobkin, R. D., Tröster, A. I., Rubino, J. T., Allen, L. A., Gara, M. A., Mark, M. H., & Menza, M. A. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12120381 · Cited by 23 · cited 1×
“Dobkin et al. (2011a, 2014) noted an association between improvements in mood and gains in executive functioning and verbal memory for depressed PD patients following face-to-face CBT.”
BackgroundManagement of impulse control disorders in Parkinson's disease
Zhang, S., Dissanayaka, N. N., Dawson, A., O'Sullivan, J. D., Mosley, P., Hall, W., & Carter, A. (2016) · International Psychogeriatrics · doi:10.1017/s104161021600096x · Cited by 22
Self-citationCognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study
Shinmei, I., Kobayashi, K., Oe, Y., Takagishi, Y., Kanie, A., Ito, M., Takebayashi, Y., Murata, M., Horikoshi, M., & Dobbin, R. D. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s104777 · Cited by 18
Ghielen, I., van den Heuvel, O. A., de Goede, C. J. T., Houniet-de Gier, M., Collette, E. H., Burgers-Bots, I. A. L., Rutten, S., Kwakkel, G., Vermunt, K., van Vliet, B., et al. (2015) · Trials · doi:10.1186/s13063-015-0804-0 · Cited by 9
Dobkin, R. D. (2014) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13030065 · Cited by 7 · cited 4×
“This is an important consideration for PD given the high prevalence of dementia, and is consistent with the findings for CBT treatment benefit for depression in PD (Dobkin et al., 2011b; Dobkin, 2014).”
BackgroundResultInfluentialRabinstein, A., & Shulman, L. (2001) · doi:10.1016/s1353-8020(01)00005-0 · Cited by 7
The impact of motor and depressive symptoms on quality of life in patients with Parkinson's disease
Jiang, J.-L., Tsai, S., Hsieh, T., Lee, C.-W., Lin, S.-H., & Chen, S.-Y. (2013) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2013.05.005 · Cited by 4 · cited 2×
“…(Riedel et al., 2010), are increasingly recognized as important contributors to patient disability (Weintraub et al., 2004), quality of life (Schrag et al., 2000; Schrag, 2006; Dissanayaka et al., 2010; Martinez-Martin et al., 2011; Jiang et al., 2013), and mortality (Hughes et al., 2004).”
Background
Cited by
Dobkin, R. D., Mann, S. L., Gara, M. A., Interian, A., Rodriguez, K. M., & Menza, M. (2020) · Neurology · doi:10.1212/wnl.0000000000009292 · Cited by 127
Pontone, G. M., Dissanayaka, N. N., Apostolova, L. G., Brown, R. G., Dobkin, R. D., Dujardin, K., Friedman, J. H., Leentjens, A. F. G., Lenze, E. J., Marsh, L., et al. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0102-8 · Cited by 74
Self-citationBogosian, A., Hurt, C. S., Hindle, J. V., McCracken, L. M., Vasconcelos e Sa, D. A., Axell, S., Tapper, K., Stevens, J., Hirani, P. S., Salhab, M., et al. (2022) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720988901 · Cited by 55
“There is evidence that distant delivered MBIs can be effective in people with chronic medical conditions.(10,14,23-25) The overall objective of this study was to assess the potential feasibility and acceptability of an MBI for PwP delivered via Skype.”
BackgroundTelepsychiatry for patients with movement disorders: a feasibility and patient satisfaction study
Seritan, A. L., Heiry, M., Iosif, A., Dodge, M., & Ostrem, J. L. (2019) · Journal of Clinical Movement Disorders · doi:10.1186/s40734-019-0077-y · Cited by 48
Synchronous Home-Based Telemedicine for Primary Care: A Review
Lindenfeld, Z., Berry, C., Albert, S., Massar, R., Shelley, D., Kwok, L., Fennelly, K., & Chang, J. E. (2023) · Medical Care Research and Review · doi:10.1177/10775587221093043 · Cited by 43
“…or clinic to connect with a provider, rather than home-based telemedicine, which refers to patients receiving care while located in their own homes (Chuchu et al., 2018; Flodgren et al., 2015; Khan et al., 2015; Laver et al., 2020; Rush et al., 2018; Swalwell et al., 2018; Wade et al., 2010).”
BackgroundInfluential
Metadata
- Authors
- Swalwell, C., Pachana, N. A., & Dissanayaka, N. N.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Dissanayaka, Nadeeka N.
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 30
- Issue
- 12
- Pages
- 1783-1795
- ISSN
- 1041-6102 (ISSN-L)
- OpenAlex
- W2799754670
- Cited by
- 87
- References
- 59
- Citations by year
- 2026: 2 · 2025: 7 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 62 · 2019: 5 · 2018: 1
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 2221 d)
- Locations
- International Psychogeriatrics (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Lions Medical Research Foundation
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Parkinson's disease, telemedicine, remote psychological intervention, neuropsychiatric symptoms, cognitive behavioral therapy, telephone-delivered intervention, videoconferencing, depression, anxiety, mindfulness-based interventions, acceptance and commitment therapy, speech therapy, treatment accessibility
- MeSH terms
- Anxiety, Depression, Female, Humans, Parkinson Disease, Psychotherapy, Quality of Life, Telephone, Cognitive Behavioral Therapy, Treatment Outcome, Telemedicine, Remote Consultation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-27, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-27 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.